Next generation programmable cancer gene therapies

• Unité de recherche: INNOSUISSE
• Numéro de projet: 120.389 IP-LS
• Titre du projet anglais: Next generation programmable cancer gene therapies

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

Pattern BioSciences develops first-in-class gene therapies using its innovative technology platform that combines synthetic biology and biomolecular computing. Together with research partner A. Moor from ETH, this project will expand its pipeline with an R&D program in metastatic colorectal cancer.